Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: Review of the dermatologic and rheumatologic literature

被引：40
作者：
Dadlani, C [1 ]
Orlow, SJ
机构：
[1] NYU, Sch Med, Dept Pediat, New York, NY USA
[2] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 02期
关键词：
D O I：
10.1016/j.jaad.2004.07.043
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：316 / 340
页数：25
相关论文
共 49 条
  • [1] Alli N, 1998, BRIT J DERMATOL, V139, P754
  • [2] Cyclosporine in severe childhood atopic dermatitis: A multicenter study
    BerthJones, J
    Finlay, AY
    Zaki, I
    Tan, B
    Goodyear, H
    LewisJones, S
    Cork, MJ
    Bleehen, SS
    Salek, MS
    Allen, BR
    Friedmann, P
    Harper, J
    Camp, RDR
    Smith, S
    GrahamBrown, RAC
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (06) : 1016 - 1021
  • [3] METHOTREXATE AND PREDNISOLONE TREATMENT OF A CHILD WITH PSORIATIC ARTHRITIS
    BJORKSTEN, B
    BACK, O
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1975, 64 (04): : 664 - 666
  • [4] Effect of oral cyclosporin A in children with Staphylococcus aureus-colonized vs. S-aureus-infected severe atopic dermatitis
    Bunikowski, R
    Mielke, M
    Bräutigam, M
    Renz, H
    Wahn, U
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2003, 14 (01) : 55 - 59
  • [5] Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis:: Clinical and immunological effects
    Bunikowski, R
    Staab, D
    Kussebi, F
    Bräutigam, M
    Weidinger, G
    Renz, H
    Wahn, U
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2001, 12 (04) : 216 - 223
  • [6] COHEN BA, 2000, PEDIAT DERMATOLOGY
  • [7] The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis
    Elkayam, O
    Caspi, D
    Reitblatt, T
    Charboneau, D
    Rubins, JB
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (04) : 283 - 288
  • [8] International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies
    Ellis, C
    Luger, T
    Abeck, D
    Allen, R
    Graham-Brown, RAC
    De Prost, Y
    Eichenfield, LF
    Ferrandiz, C
    Giannetti, A
    Hanifin, J
    Koo, JYM
    Leung, D
    Lynde, C
    Ring, J
    Ruiz-Maldonado, R
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 : 3 - 10
  • [9] Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept
    Elwood, RL
    Pelszynski, MM
    Corman, LI
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (03) : 286 - 288
  • [10] Safety and efficacy of disease-modifying anti-rheumatic agents - Focus on the benefits and risks of etanercept
    Fleischmann, R
    Iqbal, I
    Nandeshwar, P
    Quiceno, A
    [J]. DRUG SAFETY, 2002, 25 (03) : 173 - 197
12345